Health Invest Partners Ab has filed its 13F form on February 04, 2025 for Q4 2024 where it was disclosed a total value porftolio of $208 Million distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $28.6M, Unitedhealth Group Inc with a value of $17.8M, Abb Vie Inc. with a value of $16.1M, Boston Scientific Corp with a value of $13.8M, and Thermo Fisher Scientific Inc. with a value of $13M.
Examining the 13F form we can see an increase of $2.12M in the current position value, from $206M to 208M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.